Skip to main content
. 2010 Mar 31;2010:141657. doi: 10.1155/2010/141657

Table 3.

Immunity to Hepatitis C Virus—A Flavivirus with no vaccine [9, 22].

(i) 60%–80% of patients remain chronically infected and suffer consequences
(ii) Patients who do recover develop multiepitope-specific CD8+ and type 1 CD4+ T cells
(iii) Neutralizing Ab production takes 6–8 months and highest titers occur in chronics. Recovered patients may test negative
(iv) Abs always gone by 10–20 y, but specific T cells persist for life in liver (in chimps)
(v) Chimps without CD4+ or CD8+ T cells fail to control infection
(vi) Escape mutants for Ab and T cells occur readily